Semi-Annual Consolidated Statement Of Cash Flows

SanBio Company Limited - Filing #7308447

Concept 2024-02-01 to
2024-07-31
As at
2024-07-31
As at
2024-01-31
As at
2023-07-31
2023-02-01 to
2023-07-31
As at
2023-01-31
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-1,186,107,000 JPY
-1,858,809,000 JPY
Depreciation
4,943,000 JPY
8,629,000 JPY
Interest and dividend income
-1,036,000 JPY
-1,391,000 JPY
Interest expenses
4,299,000 JPY
5,652,000 JPY
Foreign exchange losses (gains)
-399,123,000 JPY
-1,131,451,000 JPY
Increase (decrease) in provision for bonuses
46,719,000 JPY
6,033,000 JPY
Other, net
36,114,000 JPY
77,666,000 JPY
Subtotal
-1,689,669,000 JPY
-2,632,341,000 JPY
Interest and dividends received
1,036,000 JPY
1,391,000 JPY
Interest paid
-4,299,000 JPY
-5,656,000 JPY
Income taxes paid
-10,879,000 JPY
-605,000 JPY
Net cash provided by (used in) operating activities
-1,703,812,000 JPY
-2,637,211,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-3,555,000 JPY
-8,698,000 JPY
Net cash provided by (used in) investing activities
-3,755,000 JPY
-8,698,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-134,000,000 JPY
-134,000,000 JPY
Net cash provided by (used in) financing activities
340,441,000 JPY
463,573,000 JPY
Other, net
-147,000 JPY
JPY
Effect of exchange rate change on cash and cash equivalents
-8,052,000 JPY
69,338,000 JPY
Net increase (decrease) in cash and cash equivalents
-1,375,178,000 JPY
-2,112,998,000 JPY
Cash and cash equivalents
3,014,341,000 JPY
4,389,520,000 JPY
4,562,200,000 JPY
6,675,198,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.